Order Article Reprints

Berciano-Guerrero M-A, Lavado-Valenzuela R, Moya A, delaCruz-Merino L, Toscano F, Valdivia J, Castellón V, Henao-Carrasco F, Sancho P, Onieva-Zafra J-L, et al. Genes Involved in Immune Reinduction May Constitute Biomarkers of Response for Metastatic Melanoma Patients Treated with Targeted Therapy. Biomedicines. 2022; 10(2):284. https://doi.org/10.3390/biomedicines10020284

Berciano-Guerrero, Miguel-Angel, Rocío Lavado-Valenzuela, Aurelio Moya, Luis delaCruz-Merino, Fátima Toscano, Javier Valdivia, Victoria Castellón, Fernando Henao-Carrasco, Pilar Sancho, Juan-Luis Onieva-Zafra, and et al. 2022. "Genes Involved in Immune Reinduction May Constitute Biomarkers of Response for Metastatic Melanoma Patients Treated with Targeted Therapy" Biomedicines 10, no. 2: 284. https://doi.org/10.3390/biomedicines10020284

Berciano-Guerrero, M.-A., Lavado-Valenzuela, R., Moya, A., delaCruz-Merino, L., Toscano, F., Valdivia, J., Castellón, V., Henao-Carrasco, F., Sancho, P., Onieva-Zafra, J.-L., Navas-Delgado, I., Rueda-Dominguez, A., Perez-Ruiz, E., & Alba, E. (2022). Genes Involved in Immune Reinduction May Constitute Biomarkers of Response for Metastatic Melanoma Patients Treated with Targeted Therapy. Biomedicines, 10(2), 284. https://doi.org/10.3390/biomedicines10020284